NCT05055635RecruitingPhase 2
Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)
ReRad III. Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy
Source: ClinicalTrials.gov · Last updated 24 Sept 2021 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This protocol aims to determine toxicity and efficacy of re-irradiation for patients with recurrences from anal cancers with dose-escalated pencil beam proton therapy either pre-operative for marginally resectable recurrences or as a definitive treatment strategy (un-resectable, operation declined etc.). The over-all aim is to improve local tumor control with acceptable side effects.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 55 (estimated)
- First submitted
- 8 Jul 2021
- Start date
- 7 Jul 2021
- Primary completion date
- 6 Jul 2027
- Lead sponsor
- University of Aarhus
- NCT number
- NCT05055635
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 55
- From 7 Jul 2021 to the primary completion date, 6 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Inability to attend full course radiotherapy and follow up in the outpatient clinic.
Other
- Distant metastases deemed without curative intended treatment options (PET-CT)
- Unable to undergo MRI, PET-CT
Who the study is looking for
- Recurrent anal cancer
- Bioptically verified (squamous cell carcinoma)
- Available dose plan from primary radiotherapy
- Previous RT (\>30Gy EQD2)
- Evaluated in MDT-conferences (Herlev, Aarhus)
- Age\>18 years
- PS 0-2
- Adequate organ function
- Written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Danish Centre for Particle Therapy Coordinator of this site? Confirm its status | Aarhus N | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.